BridgeMD
New treatment option for Quadriplegia/Tetraplegia
Official title Development and Validation of a New Questionnaire for Caregivers to Assess Hip Pain in Quadriplegic Pediatric Patients: Non-Ambulatory Hip Pain Questionnaire
ClinicalTrials.gov ID: NCT06798233
What this study is testing
- What it's testing
- The goal of this clinical trial is twofold: 1. to develop a questionnaire for care givers to assess hip pain in quadriplegic pediatric patients who are not able to communicate it independently 2.
- Time commitment: about 4 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 20
You may be able to join if
- GMFCS IV-V
- CFCS III-V
- subscription of consent
You likely can't join if
- care givers not speaking Italian or English
The study team makes the final eligibility decision.
Where it's taking place
- Pisa, Italy, Italy
- Spilamberto, Modena, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 20 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pisa, Italy, Italy; Spilamberto, Modena, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.